The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a medicament for treating latent virus infection.

摘要

The present invention provides for the use of L-2-oxothiazolidine-4-carboxylate for the preparation of a medicament for treating viral infections associated with periods of viral latency. More specifically, the medicament can be used as a prophylactic therapy to maintain the virus in a latent state and as an active treatment for recurrent viral reactivation. The medicament will facilitate a return to viral latency.